5
days
9
h
24
min

EOlife®

ASSISTING VENTILATION
WHEN EVERY SECOND COUNTS

Presentation

EOlife® is an easy-to-use medical device which makes it possible to provide ventilation in compliance with international recommendations for CPR.


ARCHEON develops a system that measures ventilation parameters and provides first aiders with real-time feedback on the quality of ventilation given to the patient.

The product is suitable for different user profiles i.e. both professional and volunteer first aiders.

Cardiac Arrest

Cardiac arrest is still the leading cause of death worldwide and survival rates remain below 5%.

One of the main challenges facing emergency first aid teams is providing patients with enough oxygen, whilst avoiding hyperventilation which, according to recent studies, occurs in almost 80% of cases.

 

 

Hyperventilation can have severe aftereffects, including barotrauma, pneumonia, reduction of the effectiveness of chest compression, reduced venous return, and increased neurological sequelae.

According to experimental studies conducted in the United States, hyperventilation can reduce the chances of survival by 70%.

5%

Survival rate of cardiac arrest

50K

Number of victims each year in France

17M

Number of victims each year worldwide

x2

According to WHO, 100% increase in the numbers of victims by 2024

80%

Rate of hyperventilation during CPR

70%

Reduction of chance of survival due to hyperventilation

<
Interested in Eolife®?